Contact the ACC Registration and Housing Center
Explore the Sessions
ACC.23/WCC features eleven learning pathways, each focusing on a different clinical specialty of cardiovascular disease. Choose to focus on one clinical area or attend sessions from an array of pathways.
Learn more about the sessions happening in each learning pathway.
Attendees will get an overview of core knowledge as well as emerging and controversial topics in electrophysiology. Sessions will focus on a wide range of topics with an emphasis on atrial fibrillation (AFib) as experts discuss the patient population, clinical developments, high-tech advancements, global AFib care and more.
Heart Failure and Cardiomyopathies
This learning pathway provides a comprehensive overview of the latest developments in the field of HF. Over the past year, there have been numerous pharmacologic and device therapy breakthroughs in the treatment of patients with HF, including treatments for HF with preserved ejection fraction, hypertrophic cardiomyopathy and cardiac amyloidosis. Experts will bring attendees up to speed on these developments and focus on the recently updated AHA/ACC/HFSA Guideline for the Management of Heart Failure.
Interventional and Structural Cardiology
This learning pathway delivers a comprehensive overview of both common and cutting-edge topics for interventional cardiologists practicing coronary, structural and endovascular medicine. Throughout the meeting, a diverse faculty representing a wide range of perspectives will cover the essentials for cardiovascular professionals from the entire care pathway.
Ischemic Heart Disease
The Ischemic Heart Disease (IHD) Learning Pathway provides a comprehensive overview of the multidisciplinary and multifaceted field of IHD. The best educators and thought leaders in the field guide attendees through a wide range of topics, addressing important issues and incorporating preventative cardiology, innovation, pharmacology, heart failure and more.
Get patient-centered learning opportunities based on important clinical dilemmas of a broad spectrum of diseases in cardiovascular medicine. Sessions focus on practical issues that cardiovascular clinicians encounter in practice and how imaging plays a central role in patient management, highlight the power of technical innovations in imaging and their impact on patient care, spotlight controversial topics in cardiovascular medicine and more.
Pediatric and Congenital Heart Disease
Attendees will have opportunities to learn from the strongest minds in the field and engage with both the nuts and bolts of clinical practice, as well as the most challenging clinical topics in invigorating and innovative sessions. Experts present difficult clinical cases and guide attendees through addressing the challenges associated with the treatment of the patients.
Prevention and Health Promotion
The world of cardiovascular prevention is exploding with respect to new therapies in lipidology, cardiometabolic disease and weight loss. Given that cardiovascular prevention as at the core of so many disciplines within cardiology, sessions in the pathway is valuable for a wide range of practitioners and cardiovascular team members.
Pulmonary Vascular Disease
This pathway features a collection of pulmonary hypertension (PH) sessions for a diverse population of providers, including those just beginning to learn about PH all the way to PH experts. Engaging sessions in the pathway address the basics of PH, review backgrounds and key pointers for more advanced clinical dilemmas in PH, and provide a sneak peak of developing treatments and diagnostic tests that will hopefully be the future of personalized medicine for patients with PH.
Check out the engaging and informative Special Topics sessions to get brought up to speed on the latest practice-changing updates, debate and discuss the state of the cardiology profession, and more.
Valvular Heart Disease
This pathway features sessions that will review current guideline-based recommendations and help clinicians learn to navigate controversies in everyday practice. Experts will address some of the key topics in VHD including hemodynamic assessment of valvular disease, emerging strategies for evaluating and managing tricuspid regurgitation (TR) and ethical dilemmas in VHD management.
Attendees will get a comprehensive overview of core topics and novel therapies in vascular disease. Sessions cover a wide range of topics, including the most popular topics from last year's meeting that need further examination, clarification and reinforcement.